Related Party Transactions - Additional Information (Details) - USD ($)	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Related Party Transaction [Line Items]
Revenue recognized	$ 38,469,000		$ 29,784,000		$ 87,132,000	$ 61,911,000
Drug discovery services revenue from contracts with customers	8,458,000		5,732,000		24,040,000	11,519,000
Restricted cash	3,500,000	$ 3,000,000			3,500,000		$ 3,000,000
Agreement with Gates Ventures, LLC
Related Party Transaction [Line Items]
Net receivables (payables)	$ 1,000	0			$ 1,000		0
Agreement with Gates Ventures, LLC | Minimum
Related Party Transaction [Line Items]
Percentage of voting securities	5.00%				5.00%
Agreement with Gates Ventures, LLC | First Anniversary
Related Party Transaction [Line Items]
Contribution revenue recognition			1,000,000	$ 1,000,000
Agreement with Gates Ventures, LLC | Second Anniversary
Related Party Transaction [Line Items]
Contribution revenue recognition	$ 1,000,000
Drug Discovery Contribution
Related Party Transaction [Line Items]
Drug discovery services revenue from contracts with customers	439,000				$ 781,000
Member of Board of Directors
Related Party Transaction [Line Items]
Payment of consulting fees	100,000		95,000		200,000	190,000
BMGFT
Related Party Transaction [Line Items]
Revenue recognized	15,000		$ 142,000		215,000	$ 872,000
Net receivables (payables)	0	165,000			0		165,000
BMGFT | Drug Discovery Contribution
Related Party Transaction [Line Items]
Net receivables (payables)	0	0			0		0
Drug discovery services revenue from contracts with customers	440,000	111,000			781,000
Restricted cash	2,891,000	$ 1,130,000			2,891,000		1,130,000
Structure Therapeutics
Related Party Transaction [Line Items]
Software sales transactions amount							$ 650,000
Revenue from related parties	$ 73,000				$ 150,000